Shortages, Supply Chains, and Systemic Gaps: The Difficult Path Chloroquine Travels to Reach American Patients
Despite decades of established use, chloroquine and hydroxychloroquine continue to face availability hurdles that leave some American patients and providers scrambling. From manufacturing concentration overseas to regional pharmacy deserts and the lingering disruptions of pandemic-era demand surges, the supply chain behind these essential medicines is more fragile than many realize.